1,114
Views
0
CrossRef citations to date
0
Altmetric
Critical Care Nephrology and Continuous Kidney Replacement Therapy

The combination of kidney function variables with cell cycle arrest biomarkers identifies distinct subphenotypes of sepsis-associated acute kidney injury: a post-hoc analysis (the PHENAKI study)

ORCID Icon, , , , , , , , & show all
Article: 2325640 | Received 25 Sep 2023, Accepted 26 Feb 2024, Published online: 06 Mar 2024

References

  • Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294(7):1–10. doi: 10.1001/jama.294.7.813.
  • Hoste EAJ, Schurgers M. Epidemiology of acute kidney injury: how big is the problem? Crit Care Med. 2008;36(4):S146–S151. doi: 10.1097/CCM.0b013e318168c590.
  • Hoste EAJ, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41(8):1411–1423. doi: 10.1007/s00134-015-3934-7.
  • Peters E, Antonelli M, Wittebole X, et al. A worldwide multicentre evaluation of the influence of deterioration or improvement of acute kidney injury on clinical outcome in critically ill patients with and without sepsis at ICU admission: results from the intensive care over nations audit. Crit Care. 2018;22(1):188. doi: 10.1186/s13054-018-2112-z.
  • Kellum JA, Lameire N. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (part 1). Crit Care. 2013;17(1):204. doi: 10.1186/cc11454.
  • Honore PM, Nguyen HB, Gong M, et al. Urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 for risk stratification of acute kidney injury in patients with sepsis. Crit Care Med. 2016;44(10):1851–1860. doi: 10.1097/CCM.0000000000001827.
  • Maizel J, Daubin D, Vong LV, et al. Urinary TIMP2 and IGFBP7 identifies high risk patients of short-term progression from mild and moderate to severe acute kidney injury during septic shock: a prospective cohort study. Dis Markers. 2019;2019:3471215–3471218. doi: 10.1155/2019/3471215.
  • Fiorentino M, Xu Z, Smith A, et al. Serial measurement of cell-cycle arrest biomarkers [TIMP-2] · [IGFBP7] and risk for progression to death, dialysis, or severe acute kidney injury in patients with septic shock. Am J Respir Crit Care Med. 2020;202(9):1262–1270. doi: 10.1164/rccm.201906-1197OC.
  • Meersch M, Schmidt C, Hoffmeier A, et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med. 2017;43(11):1551–1561. doi: 10.1007/s00134-016-4670-3.
  • Göcze I, Jauch D, Götz M, et al. Biomarker-guided intervention to prevent acute kidney injury after major surgery: the prospective randomized BigpAK study. Ann Surg. 2018;267(6):1013–1020. doi: 10.1097/SLA.0000000000002485.
  • Ostermann M, Zarbock A, Goldstein S, et al. Recommendations on acute kidney injury biomarkers from the acute disease quality initiative consensus conference: a consensus statement. JAMA Netw Open. 2020;3(10):e2019209. doi: 10.1001/jamanetworkopen.2020.19209.
  • Titeca-Beauport D, Daubin D, Van Vong L, et al. Urine cell cycle arrest biomarkers distinguish poorly between transient and persistent AKI in early septic shock: a prospective, multicenter study. Crit Care. 2020;24(1):280. doi: 10.1186/s13054-020-02984-6.
  • Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American college of chest physicians/society of critical care medicine. Chest. 1992;101(6):1644–1655. doi: 10.1378/chest.101.6.1644.
  • Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–810. doi: 10.1001/jama.2016.0287.
  • Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270(24):2957–2963. doi: 10.1001/jama.270.24.2957.
  • Vincent JL, Moreno R, Takala J, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707–710. doi: 10.1007/BF01709751.
  • Denz R, Klaaßen-Mielke R, Timmesfeld N. A comparison of different methods to adjust survival curves for confounders. Stat Med. 2023;42(10):1461–1479. doi: 10.1002/sim.9681.
  • Waegeman W, De Baets B, Boullart L. ROC analysis in ordinal regression learning. Pattern Recog Lett. 2008;29(1):1–9. doi: 10.1016/j.patrec.2007.07.019.
  • Bagshaw SM, Uchino S, Bellomo R, et al. Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol. 2007;2(3):431–439. doi: 10.2215/CJN.03681106.
  • Sood MM, Shafer LA, Ho J, et al. Early reversible acute kidney injury is associated with improved survival in septic shock. J Crit Care. 2014;29(5):711–717. doi: 10.1016/j.jcrc.2014.04.003.
  • Truche AS, Ragey SP, Souweine B, et al. ICU survival and need of renal replacement therapy with respect to AKI duration in critically ill patients. Ann Intensive Care. 2018;8(1):127. doi: 10.1186/s13613-018-0467-6.
  • Bagshaw SM, George C, Bellomo R. Early acute kidney injury and sepsis: a multicentre evaluation. Crit Care. 2008;12(2):R47. doi: 10.1186/cc6863.
  • Bagshaw SM, Lapinsky S, Dial S, et al. Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med. 2009;35(5):871–881. doi: 10.1007/s00134-008-1367-2.
  • Plataki M, Kashani K, Cabello-Garza J, et al. Predictors of acute kidney injury in septic shock patients: an observational cohort study. Clin J Am Soc Nephrol. 2011;6(7):1744–1751. doi: 10.2215/CJN.05480610.
  • Flannery AH, Kiser AS, Behal ML, et al. RAS inhibition and sepsis-associated acute kidney injury. J Crit Care. 2022;69:153986. doi: 10.1016/j.jcrc.2022.153986.
  • Macedo E, Bouchard J, Soroko SH, et al. Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients. Crit Care. 2010;14(3):R82. doi: 10.1186/cc9004.
  • Macedo E, Malhotra R, Bouchard J, et al. Oliguria is an early predictor of higher mortality in critically ill patients. Kidney Int. 2011;80(7):760–767. doi: 10.1038/ki.2011.150.
  • Leedahl DD, Frazee EN, Schramm GE, et al. Derivation of urine output thresholds that identify a very high risk of AKI in patients with septic shock. Clin J Am Soc Nephrol. 2014;9(7):1168–1174. doi: 10.2215/CJN.09360913.
  • Prowle JR, Liu YL, Licari E, et al. Oliguria as predictive biomarker of acute kidney injury in critically ill patients. Crit Care. 2011;15(4):R172. doi: 10.1186/cc10318.
  • Klein SJ, Lehner GF, Forni LG, et al. Oliguria in critically ill patients: a narrative review. J Nephrol. 2018;31(6):855–862. doi: 10.1007/s40620-018-0539-6.
  • Bhatraju PK, Zelnick LR, Herting J, et al. Identification of acute kidney injury subphenotypes with differing molecular signatures and responses to vasopressin therapy. Am J Respir Crit Care Med. 2019;199(7):863–872. doi: 10.1164/rccm.201807-1346OC.
  • Wiersema R, Jukarainen S, Vaara ST, et al. Two subphenotypes of septic acute kidney injury are associated with different 90-day mortality and renal recovery. Crit Care. 2020;24(1):150. doi: 10.1186/s13054-020-02866-x.
  • Uhel F, Peters-Sengers H, Falahi F, the MARS consortium., et al. Mortality and host response aberrations associated with transient and persistent acute kidney injury in critically ill patients with sepsis: a prospective cohort study. Intensive Care Med. 2020;46(8):1576–1589. doi: 10.1007/s00134-020-06119-x.
  • Molinari L, Del Rio-Pertuz G, Smith A, et al. Utility of biomarkers for sepsis-associated acute kidney injury staging. JAMA Netw Open. 2022;5(5):e2212709. doi: 10.1001/jamanetworkopen.2022.12709.
  • Kashani K, Al-Khafaji A, Ardiles T, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013;17(1):R25. doi: 10.1186/cc12503.
  • Vaara ST, Bhatraju PK, Stanski NL, et al. Subphenotypes in acute kidney injury: a narrative review. Crit Care. 2022;26(1):251. doi: 10.1186/s13054-022-04121-x.
  • Knox DB, Lanspa MJ, Kuttler KG, et al. Phenotypic clusters within sepsis-associated multiple organ dysfunction syndrome. Intensive Care Med. 2015;41(5):814–822. doi: 10.1007/s00134-015-3764-7.
  • Seymour CW, Kennedy JN, Wang S, et al. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA. 2019;321(20):2003–2017. doi: 10.1001/jama.2019.5791.
  • Uchino S, Bellomo R, Bagshaw SM, et al. Transient azotaemia is associated with a high risk of death in hospitalized patients. Nephrol Dial Transplant. 2010;25(6):1833–1839. doi: 10.1093/ndt/gfp624.